In just over 3 weeks our Parallel Trade conference returns for its 8th year. With 9 of the top 12 pharmaceutical companies in attendance, this event is a must attend. Please check the website for the latest updated programme
This presentation by Margherita COLANGELO, Associate Professor of Comparative Law, University of Roma Tre, was made during the discussion “Excessive Pricing in Pharmaceuticals” held at the 130th meeting of the OECD Competition Committee on 28 November 2018. More papers and presentations on the topic can be found out at oe.cd/exph.
Key issues in alcohol policy at EU leveltamsin.rose
Presentation outlining some of the aspects of alcohol policy at European level and the potential winners and losers in the new EU Alcohol and Health Strategy
French generics market attractiveness 2017 - 2022 excerptJean-Michel Peny
This excerpt of a report published in 2017 describes and explains the dynamics of the French generics and biosimilars markets in France, and evaluate their attractiveness by 2022
This presentation by Margherita COLANGELO, Associate Professor of Comparative Law, University of Roma Tre, was made during the discussion “Excessive Pricing in Pharmaceuticals” held at the 130th meeting of the OECD Competition Committee on 28 November 2018. More papers and presentations on the topic can be found out at oe.cd/exph.
Key issues in alcohol policy at EU leveltamsin.rose
Presentation outlining some of the aspects of alcohol policy at European level and the potential winners and losers in the new EU Alcohol and Health Strategy
French generics market attractiveness 2017 - 2022 excerptJean-Michel Peny
This excerpt of a report published in 2017 describes and explains the dynamics of the French generics and biosimilars markets in France, and evaluate their attractiveness by 2022
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...Office of Health Economics
This research presented in a poster at HTAi 2019, Cologne (Germany) by a team of OHE and IHE researchers, estimates the value added by second generation antipsychotics over their life-cycle in the UK and Sweden. It concludes that considering the entire life-cycle, the value added by SGAs to the system is higher than the expected value estimated at launch. P&R decisions should consider how to measure, capture and take into account the value added by medicines over the long-run.
Author(s) and affiliation(s): Mikel Berdud (Office of Health Economics, London), Niklas Wallin-Bernhardsson (Institute for Health Economics, Stockholm), Bernarda Zamora (Office of Health Economics, London), Peter Lindgren (Institute for Health Economics, Stockholm), Adrian Towse (Office of Health Economics, London)
Event: HTAi 2019 Annual Meeting
Date: 18/06/2019
Location: Cologne, Germany
This presentation by Martin WENZL from the OECD Health Division was made during the discussion “Excessive Pricing in Pharmaceuticals” held at the 130th meeting of the OECD Competition Committee on 28 November 2018. More papers and presentations on the topic can be found out at oe.cd/exph.
This presentation by Pedro CARO DE SOUSA from the OECD Competition Division was made during the discussion “Excessive Pricing in Pharmaceuticals” held at the 130th meeting of the OECD Competition Committee on 28 November 2018. More papers and presentations on the topic can be found out at oe.cd/exph.
This presentation from the EU was made during the discussion “Excessive Pricing in Pharmaceuticals” held at the 130th meeting of the OECD Competition Committee on 28 November 2018. More papers and presentations on the topic can be found out at oe.cd/exph.
This presentation by Panos Kanavos was made at the 2014 Global Forum on Competition (27-28 February) at the session on competition issues in the distribution of pharmaceuticals. Find out more at http://www.oecd.org/competition/globalforum
This presentation by Sabine Vogler was made at the 2014 Global Forum on Competition (27-28 February) during the session on competition issues in the distribution of pharmaceuticals. Find out more at http://www.oecd.org/competition/globalforum
SMi Group presents the 23rd annual industry leading summit on Pharmaceutical Pricing & Market Access, 11 – 12 Oct 2017, London, UK.
Pharmaceutical Pricing & Market Access 2017 will tackle industry challenges head on by preparing attendees to develop a successful market access strategy for the ever changing pharmaceutical and payer landscape. Join us this autumn for insight into how manufactures plan to limit further price increase; a progressive outlook into the future of pharmaceutical pricing & reimbursement (P&R); stakeholder collaboration; meaningful patient engagement opportunities; and discuss what can be done for the industry to achieve efficient reimbursement and for patients to gain access to affordable medication.
Highlights will include an exclusive opening keynote from the FDA and interactive training on Real World Evidence (RWE). Featured Speakers include: Lundbeck, FDA, Shire, Sobi, Teva, Grifols, Allergan, Sanofi and more!
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...Office of Health Economics
This research presented in a poster at HTAi 2019, Cologne (Germany) by a team of OHE and IHE researchers, estimates the value added by second generation antipsychotics over their life-cycle in the UK and Sweden. It concludes that considering the entire life-cycle, the value added by SGAs to the system is higher than the expected value estimated at launch. P&R decisions should consider how to measure, capture and take into account the value added by medicines over the long-run.
Author(s) and affiliation(s): Mikel Berdud (Office of Health Economics, London), Niklas Wallin-Bernhardsson (Institute for Health Economics, Stockholm), Bernarda Zamora (Office of Health Economics, London), Peter Lindgren (Institute for Health Economics, Stockholm), Adrian Towse (Office of Health Economics, London)
Event: HTAi 2019 Annual Meeting
Date: 18/06/2019
Location: Cologne, Germany
This presentation by Martin WENZL from the OECD Health Division was made during the discussion “Excessive Pricing in Pharmaceuticals” held at the 130th meeting of the OECD Competition Committee on 28 November 2018. More papers and presentations on the topic can be found out at oe.cd/exph.
This presentation by Pedro CARO DE SOUSA from the OECD Competition Division was made during the discussion “Excessive Pricing in Pharmaceuticals” held at the 130th meeting of the OECD Competition Committee on 28 November 2018. More papers and presentations on the topic can be found out at oe.cd/exph.
This presentation from the EU was made during the discussion “Excessive Pricing in Pharmaceuticals” held at the 130th meeting of the OECD Competition Committee on 28 November 2018. More papers and presentations on the topic can be found out at oe.cd/exph.
This presentation by Panos Kanavos was made at the 2014 Global Forum on Competition (27-28 February) at the session on competition issues in the distribution of pharmaceuticals. Find out more at http://www.oecd.org/competition/globalforum
This presentation by Sabine Vogler was made at the 2014 Global Forum on Competition (27-28 February) during the session on competition issues in the distribution of pharmaceuticals. Find out more at http://www.oecd.org/competition/globalforum
SMi Group presents the 23rd annual industry leading summit on Pharmaceutical Pricing & Market Access, 11 – 12 Oct 2017, London, UK.
Pharmaceutical Pricing & Market Access 2017 will tackle industry challenges head on by preparing attendees to develop a successful market access strategy for the ever changing pharmaceutical and payer landscape. Join us this autumn for insight into how manufactures plan to limit further price increase; a progressive outlook into the future of pharmaceutical pricing & reimbursement (P&R); stakeholder collaboration; meaningful patient engagement opportunities; and discuss what can be done for the industry to achieve efficient reimbursement and for patients to gain access to affordable medication.
Highlights will include an exclusive opening keynote from the FDA and interactive training on Real World Evidence (RWE). Featured Speakers include: Lundbeck, FDA, Shire, Sobi, Teva, Grifols, Allergan, Sanofi and more!
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
Acetabularia Information For Class 9 .docxvaibhavrinwa19
Acetabularia acetabulum is a single-celled green alga that in its vegetative state is morphologically differentiated into a basal rhizoid and an axially elongated stalk, which bears whorls of branching hairs. The single diploid nucleus resides in the rhizoid.
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
Safalta Digital marketing institute in Noida, provide complete applications that encompass a huge range of virtual advertising and marketing additives, which includes search engine optimization, virtual communication advertising, pay-per-click on marketing, content material advertising, internet analytics, and greater. These university courses are designed for students who possess a comprehensive understanding of virtual marketing strategies and attributes.Safalta Digital Marketing Institute in Noida is a first choice for young individuals or students who are looking to start their careers in the field of digital advertising. The institute gives specialized courses designed and certification.
for beginners, providing thorough training in areas such as SEO, digital communication marketing, and PPC training in Noida. After finishing the program, students receive the certifications recognised by top different universitie, setting a strong foundation for a successful career in digital marketing.
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
1. BOOK BY ER
OB
31ST OCT
“Invaluable conference that will help
us in the area of parallel imports”
0
SAVE £30
Y
BOOK B BER
VEM
29TH NO
0
SAVE £10
SMi presents their 8th annual...
10TH - 11TH
Parallel Trade FEB
Marriott Regents Park Hotel, London, UK
2014
NEW FOR 2014
KEY SPEAKERS:
• How to comply with current and
forthcoming pharmaceutical legislation
• Gain a diverse perspective on parallel
trade from Johnson & Johnson Diabetes
Solutions Companies
• Discuss the impact of government
policies on parallel trade in Europe
• Perspective of traders – putting the
spotlight on best practice within industry
• Key panel discussion with LEO Pharma
and Biogen Idec plus Don Macarthur
and Panos Kanavos
• Dick Saunders, Commercial Manager, Johnson & Johnson
Diabetes Solutions Companies
• Hélène Juramy, Case Handler, European Commission
• Eric Noehrenberg, Director, Public Affairs for Market Access, Shire
Pharmaceuticals Group Plc
• Joe van den Bergh, Director, Jeron Medical Limited
• Maarten Van Baelen, Medical Affairs Manager, European Generic
Medicines Association
• Dimitrios Karageorgiou, General Secretary, Panhellenic
Pharmacists Association, Greece
• Janice Haigh, Practice Leader, Market Access, Quintiles
• Craig Stobie, Global Life Sciences Sector Manager, Domino
Printing Sciences
• Panos Kanavos, Reader, International Health Policy, London School
of Economics and Political Science
PLUS ONE INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOP
Wednesday 12th February 2014, Marriott Regents Park Hotel, London, UK
Parallel trade management strategies
Hosted by Janice Haigh, Practice Leader, Market Access, Europe, Quintiles Consulting
8.30am - 12.30pm
Sponsored by
www.parallel-trade.com
BOOK BY 31ST OCTOBER AND SAVE £300 / BOOK BY 29TH NOVEMBER AND SAVE £100
Register online or fax your registration to +44 (0) 870 9090 712 or call +44 (0) 870 9090 711
2. Parallel trade
www.paralle
Day One | Monday 10th February 2014
8.30
9.00
Registration & Coffee
EXPLORING MARKET OUTLOOKS
Chairman's Opening Remarks
Eric Noehrenberg, Director, Public Affairs, Market Access,
1.30
Shire Pharmaceuticals Group Plc
• Has government price setting changed?
• Have other government policies changed?
OPENING ADDRESS / KEYNOTE ADDRESS
9.10
How have government policies responded to parallel trade?
• Have patterns of parallel trade changed following the
Overview of parallel trade as a technique
• Why is it happening?
ascension of new member states?
• Contrasting perspectives on the phenomenon
Margaret Kyle, Professor, Toulouse School of Economics, France
• How to approach parallel trade going forward
Eric Noehrenberg, Director, Public Affairs, Market Access,
Shire Pharmaceuticals Group Plc
2.10
Falsified Medicines Directive – implementing safety features
• Costs for the generic medicines industry
LEGISLATION – KEY POINTS AND HOW TO COMPLY WITH DIRECTIVES
• Risks for the supply chain
9.50
Parallel trade within the EU – a competition regulator’s viewpoint
• Setting up repository systems
• Parallel trade of pharmaceuticals in the EU: context and policy
debate
Maarten Van Baelen, Medical Affairs Manager, European
• Assessing parallel trade under competition rules: economic
Generic Medicines Association
and legal framework
• A look at recent trends: industry and regulatory developments
Hélène Juramy, Case Officer, European Commission
Parallel trade and competition law – an update
Morning Coffee
10.50
Afternoon Tea
3.10
10.30
2.50
Past, present and future of pharmaceutical parallel trading
• Why is competition law relevant?
• Why and how did parallel trading start?
• Exploring the development of parallel trade and legislation
• The European Commission’s renewed interest in parallel trade
• Discussion of current issues and future issues in parallel trade
• Update on national developments
Joe van den Bergh, Director, Jeron Medical Limited
11.30
Axel Schulz, Partner, White & Case LLP
What the Falsified Medicines Directive means for parallel trade
• Considering the building blocks of current legislation
3.50
Imports from new Member States and the Specific Mechanism
• How to get a compliant product to market – evaluating the
• When and why can patents be asserted against imports within
impact of 2014 legislation on the pharmaceutical industry
• Parallel traders as manufacturers – where you sell product
the EEA?
versus making product – simplifying the conundrum
• Exploring Merck v Sigma: UK judgments and reference to ECJ
• Revealing the hidden challenges of serialisation and
• Discussion of practical implications going forward
traceability
Craig Stobie, Global Life Sciences Sector Manager, Domino
Dr Christopher Stothers, Partner, Arnold and Porter
Printing Sciences
12.10
Networking Lunch
4.30
Chairman's Closing Remarks and Close of Day One
Register online at: www.parallel-trade.com • Alternatively fax yo
Sponsored by
SPONSORSHIP AND EXHIBITION
OPPORTUNITIES
Domino has a global reputation for the development and
manufacture of coding, marking and printing technologies.
Innovative ink jet, laser, print & apply and thermal transfer
overprinting technologies are deployed for the application of
variable data, bar codes and unique traceability codes onto
product
and
packaging,
across
sectors
including
pharmaceutical, food, beverage and industrial products.
www.domino-printing.com
SMi offer sponsorship, exhibition, advertising
and branding packages, uniquely tailored to
complement your company’s marketing
strategy. Prime networking opportunities exist
to entertain, enhance and expand your client
base within the context of an independent
discussion specific to your industry.
Should you wish to join the increasing number
of companies benefiting from sponsoring our
conferences please call:
Alia Malick on +44 (0) 20 7827 6168 or
email: amalick@smi-online.co.uk
3. el-trade.com
Day Two | Tuesday 11th February 2014
8.30
Registration & Coffee
9.00
Chairman's Opening Remarks
Peter Sinis, Senior Manager, Decision Support, Biogen Idec
Eric Noehrenberg, Director, Shire Pharmaceuticals Group Plc
Mr Don Macarthur, Independent Global Pharmaceutical Business
1.30
PANEL DISCUSSION
– challenges in the local market and internationally
Analyst, DM Pharma Issues
OPENING ADDRESS / KEYNOTE ADDRESS
9.10
Dr Panos Kanavos, Reader, International Health Policy, London
Perspectives on parallel trade throughout the supply chain
School of Economics and Political Science
• Best practice from manufacturer to patient defined
Tim Hammond, Head of Global Pricing, LEO Pharma
• Discussion of different systems and processes undertaken to
manage parallel trade
MACRO DYNAMICS OF PARALLEL TRADE
Dick Saunders, Commercial Manager, Johnson & Johnson
Diabetes Solutions Companies
2.10
How market dynamics influence the incentives for parallel trade
• The impact of parallel trade on stock management
WHAT DOES BEST PRACTICE MEAN?
and stock-outs
9.50
Initiatives of parallel distributors in the context of the Falsified
• Managing parallel trade – ensuring best practice on
Medicines Directive
tracking exports
• Good parallel distribution guidelines
• Discussing anti-counterfeiting relating to parallel trade –
• Discussing the early warning anti-counterfeit platform
exporting and importing
• Joint Audits initiative
• Evaluating the importance of transparency in wholesaling
• Collaboration with other stakeholders
Speaker to be confirmed
Tomasz Dzitko, Founder and CEO, Delfarma
10.30
Morning Coffee
10.50
Parallel distribution update 2014
2.50
Afternoon Tea
3.10
The impact of parallel imports on social welfare
• How does the allocation of price / sales change after the entry
• Integration of parallel distributors into European Medicines
of importers?
Verification System
• How does parallel trade regulation affect the marketing
• Medicines shortages: the broader picture
behaviour of firms?
• The new disease: export restrictions
Heinz Kobelt, Director, European Affairs, European Association
• How do innovative firms respond to competition in on-patent
of Euro-Pharmaceutical companies
markets?
Moritz Suppliet, Doctoral Researcher, Düsseldorf Institute for
11.30
Shortages of medicines and parallel trade
Competition Economics
• Description of the current situation – the reality of functioning at
the edge of the humanitarian crisis in the health sector
• Analysis of the factors causing shortages of medicines
3.50
Parallel trade as part of pricing strategy
• How should parallel trade be managed as part of a global
• Transformations and structural changes affecting the normality
pricing strategy?
of the pharmaceutical market, social behaviours and the role
• How can we implement dual pricing strategies?
of media propaganda
• Pharmacists within and against parallel trade
Dimitrios Karageorgiou, Secretary General, Panhellenic
• What other price strategies should we consider?
Pharmacists Association, Greece
12.10
• How narrow does the price corridor need to be?
Janice Haigh, Practice Leader, Market Access, Quintiles
Networking Lunch
4.30
Chairman’s Closing Remarks and Close of Day Two
our registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711
Supported by
Want to know how you
can get involved?
Interested in promoting your
services to this market?
Contact Catarina Almeida,
SMi Marketing on
+44 (0) 20 7827 6014, or email:
calmeida@smi-online.co.uk
4. POST-CONFERENCE WORKSHOP
Wednesday 12th February 2014
8.30am - 12.30pm
Marriott Regents Park Hotel, London, UK
Parallel trade
management strategies
Workshop Leader:
Janice Haigh, Practice Leader, Market Access,
Quintiles Consulting
Overview of workshop:
Following feedback from SMi’s Parallel Trade
Conference in February 2013 and a further masterclass
in July 2013, this sell-out workshop will again run alongside
our 2014 conference.
Parallel Trade continues to bring challenges to
pharmaceutical manufacturers, challenges including
logistics and supply, challenges of measuring and
motivating affiliates in import and export markets and
challenges around revenue and profit.
This workshop is designed to help you address these
challenges;
provide
practical
advice
and
implementable strategies. The workshop agenda will
review the available strategic options including pricing
and supply management and will give clear
recommendations.
A key focus of the workshop will be offering practical
guidance for implementation. Ample time will be
allowed for questions and discussion.
Programme
8.30
Registration & Coffee
9.00
Welcome & Introductions
9.10
Background to Parallel Trade
9.30
PT management strategies
9.50
Introduction to supply chain management
10.20
Morning Refreshments
10.50
Critical success factors
11.20
Review of tactical details
12.00
Q&A
12.30
Close of workshop
About the workshop host
Janice Haigh joined Quintiles Consulting in Jan 2011 as
Practice Leader for Market Access in Europe, she brings
theoretical knowledge, analytical insights and hands on
experience to this workshop.
Prior to this, she was Senior Director of pricing and market
access for Astellas pharma Europe with responsibility for:
•Development and implementation of pricing and
market access strategy for new and in-market
products, working closely with brand teams and
affiliates
• Price management (analysing effect of price changes
on other markets)
• Design and implementation of delivery of Astellas’s
supply chain integrity programme which ensured the
matching of supply and demand of products in
Europe.
Before joining Astellas in 2006, Janice worked in
consultancy for 20 years, including almost 10 years at IMS
health/ Cambridge Pharma Consultancy.
Responsible for leading products involving pricing,
parallel trade, health economics and health policy.
Clients included European and global pharmaceutical
companies but also trade associations and government
bodies such as the European Commission.
5. SMi PHARMACEUTICALS
FORWARD PLANNER 2013-2014
OCTOBER
Biosimilars & Biobetters
1 – 2 October 2013, London
Diabetes
1 – 2 October 2013, London
Orphan Drugs
14 – 15 October 2013, London
COPD: Novel Therapeutics and
Management Strategies
16 – 17 October 2013, London
European Pharmaceutical Pricing
& Reimbursement
21 – 22 October 2013, London
Point of Care Diagnostics - Market
Opportunities and Technology Trents
23 – 24 October 2013, London
NOVEMBER
Cell Based Assays
18 – 19 November 2013, London
Clinical Trials in CNS
18 – 19 November 2013, London
DECEMBER
Cold Chain Distribution
3 – 4 December 2013, London
JANUARY
Pharmaceutical Microbiology
20 – 21 January 2014, London
Social Media in the Pharmaceutical Industry
22 – 23 January 2014, London
Quality By Design
22 – 23 January 2014, London
Pre-Filled Syringes
27 – 28 January 2014, London
FEBRUARY
Parallel Trade
10 – 11 February 2014, London
Advances and Progress in Drug Design
17 – 18 February 2014, London
Quality by Design
24 – 25 February 2014, London
MARCH
Superbugs and Superdrugs
- A Focus on Antibacterials
5 – 6 March 2014, London
Imaging in Cancer Drug Development
12 – 13 March 2014, London
Controlled Release
12 – 13 March 2014, London
Paediatric Clinical Trials
24 – 25 March 2014, London
Adaptive Designs
24 – 25 March 2014, London
SMi offer sponsorship, exhibition, advertising
and branding packages, uniquely tailored to
complement your company's marketing
strategy. Prime networking opportunities exist to
entertain, enhance and expand your client
base within the context of an independent
discussion specific to your industry. Should you
wish to join the increasing number of
companies benefiting from sponsoring our
conferences please call: Alia Malick
Sponsorship Director on +44 20 7827 6168 or
email: amalick@smi-online.co.uk
6. PARALLEL TRADE
Conference: Monday 10th & Tuesday11th February 2014, Marriott Regents Park Hotel, London, UK
Workshop: Wednesday 12th February 2014, London
4 WAYS TO REGISTER
www.parallel-trade.com
FAX your booking form to +44 (0) 870 9090 712
PHONE on +44 (0) 870 9090 711
POST your booking form to: Events Team, SMi Group Ltd, 2nd Floor
South, Harling House, 47-51 Great Suffolk Street, London, SE1 0BS, UK
EARLY BIRD □
DISCOUNT □
Book by 31st October to receive a £300 discount off the conference price
Book by 29th November to receive a £100 discount off the conference price
CONFERENCE PRICES
Unique Reference Number
Our Reference
I would like to attend: (Please tick as appropriate)
LV P-094
Total
COMMERCIAL ORGANISATIONS
□ Conference and Workshop
Please complete fully and clearly in capital letters. Please photocopy for additional delegates.
Forename:
Surname:
£2098.00
+VAT
£2517.60
□ Conference only
DELEGATE DETAILS
Title:
Fee
£1499.00
+VAT
£1798.80
□ Workshop only
£599.00
+VAT
£718.80
£999.00
+ VAT
£1198.80
PROMOTIONAL LITERATURE DISTRIBUTION
Job Title:
□ Distribution of your company’s promotional
Department/Division:
literature to all conference attendees
Company/Organisation:
Email:
The conference fee includes refreshments, lunch, conference papers and access
Company VAT Number:
to the Document Portal containing all of the presentations.
Address:
LIVE STREAMING/ON DEMAND/ DOCUMENTATION
Town/City:
Post/Zip Code:
Country:
Direct Tel:
Direct Fax:
Unable to travel, but would like to watch the conference live, ask questions,
participate as if you were in the room.
Price
Total
□ Live Streaming
□ On demand
Mobile:
Switchboard:
£999.00 + VAT (UK) £1198.80
£599.00 + VAT (UK) £718.80
(available 24 hours after the event)
Signature:
Date:
I agree to be bound by SMi's Terms and Conditions of Booking.
on the Document Portal
£499.00 + VAT
£499.00 (or only £300 if ordered with the Document Portal)
ACCOUNTS DEPT
Title:
□ Access to the conference documentation
□ The Conference Presentations - paper copy
Forename:
Surname:
Email:
£598.80
£499.00
PAYMENT
Address (if different from above):
Payment must be made to SMi Group Ltd, and received before the event, by one of
the following methods quoting reference P-094 and the delegate’s name. Bookings
made within 7 days of the event require payment on booking, methods of payment
are below. Please indicate method of payment:
Town/City:
Post/Zip Code:
Country:
Direct Tel:
Direct Fax:
VENUE Marriott Regents Park Hotel, 128 King Henry's Road, London, NW3 3ST
□ Please contact me to book my hotel
Alternatively call us on +44 (0) 870 9090 711,
email: hotels@smi-online.co.uk or fax +44 (0) 870 9090 712
Terms and Conditions of Booking
Payment: If payment is not made at the time of booking, then an invoice will be issued and must be
paid immediately and prior to the start of the event. If payment has not been received then credit
card details will be requested and payment taken before entry to the event. Bookings within 7 days
of event require payment on booking. Access to the Document Portal will not be given until payment
has been received.
Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, another
delegate to take your place at any time prior to the start of the event. Two or more delegates may
not ‘share’ a place at an event. Please make separate bookings for each delegate.
Cancellation: If you wish to cancel your attendance at an event and you are unable to send a
substitute, then we will refund/credit 50% of the due fee less a £50 administration charge, providing
that cancellation is made in writing and received at least 28 days prior to the start of the event.
Regretfully cancellation after this time cannot be accepted. We will however provide the
conferences documentation via the Document Portal to any delegate who has paid but is unable
to attend for any reason. Due to the interactive nature of the Briefings we are not normally able to
provide documentation in these circumstances. We cannot accept cancellations of orders placed
for Documentation or the Document Portal as these are reproduced specifically to order. If we have
to cancel the event for any reason, then we will make a full refund immediately, but disclaim any
further liability.
Alterations: It may become necessary for us to make alterations to the content, speakers, timing,
venue or date of the event compared to the advertised programme.
Data Protection: The SMi Group gathers personal data in accordance with the UK Data Protection
Act 1998 and we may use this to contact you by telephone, fax, post or email to tell you about other
products and services. Unless you tick here □ we may also share your data with third parties offering
complementary products or services. If you have any queries or want to update any of the data that
we hold then please contact our Database Manager databasemanager@smi-online.co.uk or visit
our website www.smi-online.co.uk/updates quoting the URN as detailed above your address on the
attached letter.
□ UK BACS
□ Wire Transfer
□ Cheque
□ Credit Card
Sort Code 300009, Account 00936418
Lloyds TSB Bank plc, 39 Threadneedle Street, London, EC2R 8AU
Swift (BIC): LOYDGB21013, Account 00936418
IBAN GB48 LOYD 3000 0900 9364 18
We can only accept Sterling cheques drawn on a UK bank.
□ Visa □ MasterCard □ American Express
All credit card payments will be subject to standard credit card charges.
□□□□ □□□□ □□□□ □□□□
Valid From □□/□□ Expiry Date □□/□□
CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX card
Card No:
Cardholder’s Name:
Signature:
Date:
I agree to be bound by SMi's Terms and Conditions of Booking.
Card Billing Address (If different from above):
VAT
VAT at 20% is charged on the attendance fees for all delegates. VAT is also charged on live
Streaming, on Demand, Document portal and literature distribution for all UK customers and
for those EU Customers not supplying a registration number for their own country here.
______________________________________________________________________________________________
If you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email them at events@smi-online.co.uk